𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial to topotecan in hepatocellular carcinoma: A Southwest Oncology Group study

✍ Scribed by James G. Wall; Jacqueline K. Benedetti; Mark A. O'Rourke; Ronald B. Natale; John S. Macdonald

Book ID
110229823
Publisher
Springer US
Year
1997
Tongue
English
Weight
23 KB
Volume
15
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant therapy of osteosarcomaβ€”A Phase
Adjuvant therapy of osteosarcomaβ€”A Phase II trial : Southwest Oncology Group study 9139
✍ Mark M. Zalupski; Cathryn Rankin; James R. Ryan; David R. Lucas; Jeffrey Muler; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract ## BACKGROUND The objective of this study was to estimate the time to treatment failure and survival rate of the three‐drug combination of doxorubicin, cisplatin, and ifosfamide as primary and postoperative, adjunctive treatment for teenagers and adults with osteosarcoma (OS). ## METH

Phase II evaluation of mitoxantrone in a
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study
✍ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v